NCT05680961

Brief Summary

The purpose of this study is to evaluate whether New Touch Digital (NTD) NeuroRPM software installed on wearable devices can objectively measure and track symptoms in patients with Parkinson's disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 19, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

June 21, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

January 11, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

January 11, 2023

Status Verified

December 1, 2022

Enrollment Period

1.4 years

First QC Date

June 21, 2022

Last Update Submit

December 27, 2022

Conditions

Keywords

Parkinson's disease

Outcome Measures

Primary Outcomes (1)

  • NeuroRPM UPDRS predicted score vs. clinical raters' UPDRS

    We will compare symptom severity as predicted by NeuroRPM to UPDRS scores from clinical raters. Statistical significance will be evaluated by intraclass correlation and kappa-statistic.

    Comparison will be performed upon completion of the study, approximately in 1 year.

Study Arms (1)

Parkinson's patients

Cohort of patients with clinical diagnosis of Parkinson's diseases with varied symptoms and severity.

Device: Monitoring Device

Interventions

Monitoring Device

Parkinson's patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study is open to persons 18 years of age and older with a clinical diagnosis of Parkinson's diseases without other neurological diseases.

You may qualify if:

  • Subject is 18 years of age or older
  • Subject is able to provide informed written consent
  • Subject has been clinically diagnosed with Parkinson's Disease
  • Subject is mentally and physically capable of performing tasks on the mobile device and related physical activities herein described

You may not qualify if:

  • Inability to give informed consent
  • Presence of additional neurological disease aside from the diseases being studied
  • Inability to understand and follow the directions for the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parkinson's & Movement Disorders Center of Maryland

Elkridge, Maryland, 21075, United States

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Monitoring, Physiologic

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2022

First Posted

January 11, 2023

Study Start

January 19, 2019

Primary Completion

June 1, 2020

Study Completion

August 1, 2023

Last Updated

January 11, 2023

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations